S
NVO

Sunpointe’s Novo Nordisk NVO Stock Holding History

Sunpointe’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,202
Closed -$1.12M – 265
2025
Q2 		$1.12M Buy
+16,202
New +$1.1M 0.44% 51
2025
Q1 		– Sell
-6,952
Closed -$598K – 197
2024
Q4 		$598K Buy
6,952
+218
+3% +$23.6K 0.3% 72
2024
Q3 		$802K Sell
6,734
-195
-3% -$26K 0.66% 33
2024
Q2 		$989K Buy
6,929
+172
+3% +$22.8K 0.64% 33
2024
Q1 		$874K Buy
6,757
+372
+6% +$44.3K 0.97% 25
2023
Q4 		$661K Buy
+6,385
New +$631K 0.84% 29

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sunpointe's NVO Position: Q3 2025 in Review

Sunpointe sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 16,202 shares — an estimated $1.12M sold.

Sunpointe first reported a position in NVO in Q4 2023 and held it in 6 quarters. The position peaked at $1.12M in Q2 2025. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Sunpointe reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Sunpointe sold 16,202 Novo Nordisk shares in Q3 2025, an estimated $1.12M.
  • Sunpointe first reported a position in Novo Nordisk in Q4 2023 and held it in 6 quarters.
  • Sunpointe's Novo Nordisk position peaked at $1.12M in Q2 2025.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Sunpointe's 13F filing for Q3 2025, filed 12 Nov 2025.